suramin has been researched along with leuprolide in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Crawford, ED; DeAntoni, E | 1 |
| Bergan, RC; Cooper, MR; Figg, WD; Headlee, D; Humphrey, J; Reed, E; Sartor, O; Thibault, A | 1 |
| Bergan, RC; Cooper, MR; Dawson, NA; Figg, WD; Myers, CE; Reed, E; Sartor, O; Sausville, EA; Senderowicz, AM; Steinberg, SM; Tompkins, A; Weinberger, B | 1 |
| Harbour, D; Liebmann, J; Smith, A | 1 |
| Crawford, ED; Eisenberger, MA; Fisher, EI; Hussain, M; O'Connor, J; Petrylak, DP; Small, EJ; Wood, DP | 1 |
| Figg, WD; Linehan, WM; Myers, CE; Rehak, NN; Venzon, D; Walther, MM | 1 |
1 review(s) available for suramin and leuprolide
| Article | Year |
|---|---|
[Recent multicenter study protocols in the USA for patients with metastatic prostatic carcinoma].
Topics: Antineoplastic Agents, Hormonal; Combined Modality Therapy; Flutamide; Humans; Leuprolide; Male; Multicenter Studies as Topic; Neoplasm Staging; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Suramin; Survival Rate; Treatment Outcome | 1995 |
2 trial(s) available for suramin and leuprolide
| Article | Year |
|---|---|
Phase II trial of suramin, leuprolide, and flutamide in previously untreated metastatic prostate cancer.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Drug Administration Schedule; Flutamide; Humans; Leuprolide; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Suramin; Survival Analysis; Treatment Outcome | 1997 |
Androgen deprivation and four courses of fixed-schedule suramin treatment in patients with newly diagnosed metastatic prostate cancer: A Southwest Oncology Group Study.
Topics: Adult; Aged; Androgens; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Drug Administration Schedule; Feasibility Studies; Goserelin; Humans; Hydrocortisone; Leuprolide; Male; Middle Aged; Orchiectomy; Prostatic Neoplasms; Suramin; Treatment Outcome | 2000 |
4 other study(ies) available for suramin and leuprolide
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Acute renal toxicity associated with suramin in the treatment of prostate cancer.
Topics: Acute Kidney Injury; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Combined Modality Therapy; Creatinine; Flutamide; Humans; Hydrocortisone; Kidney; Leuprolide; Male; Middle Aged; Prostatic Neoplasms; Suramin | 1994 |
Acute renal failure in a patient receiving treatment with suramin.
Topics: Acute Kidney Injury; Adenocarcinoma; Androgen Antagonists; Anti-Inflammatory Agents; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Flutamide; Humans; Hydrocortisone; Leuprolide; Lumbar Vertebrae; Male; Middle Aged; Prostatic Neoplasms; Sacrum; Spinal Neoplasms; Suramin; Thoracic Vertebrae | 1997 |
Suramin administration is associated with a decrease in serum calcium levels.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Calcium; Drug Administration Schedule; Drug Resistance; Hormones; Humans; Hydrocortisone; Leuprolide; Male; Pilot Projects; Prostatic Neoplasms; Retreatment; Retrospective Studies; Suramin | 2000 |